Browse by author
Lookup NU author(s): Dr Anne Lennard
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The non-Hodgkin's lymphomas (NHL) are a heterogenous group of disorders characterised by malignant proliferation of lymphoid cells. The cellular origin is relatively well established with subtypes corresponding to the various stages of lymphocyte differentiation. The term encompasses a hotchpotch of conditions with very different morphological appearance, behaviour and clinical outcome. NHL comprise 2.4% of all cancers, with incidence increasing with age. The commonest presentation is with progressive lymphadenopathy, though extranodal manifestations are present in a significant proportion. The clinical behaviour ranges from a benign, indolent course to rapidly progressive disease; prognosis varies from weeks to many years. Treatment is correspondingly diverse, from 'watchful waiting' to high-dose chemotherapy with bone marrow stem cell transplantation. Cure is possible in an increasing number of patients and much interest currently lies in identifying patients with high-risk disease necessitating the use of intensive treatment regimens.
Author(s): Mounter PJ, Lennard AL
Publication type: Article
Publication status: Published
Journal: Postgraduate Medical Journal
Year: 1999
Volume: 75
Issue: 879
Pages: 2-6
Print publication date: 01/01/1999
ISSN (print): 0032-5473
ISSN (electronic): 1469-0756
